Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Jacques Kiladjian

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Annals of Hematology|March 9, 2019
Thromboembolic events in polycythemia veraMartin Griesshammer, Jean-Jacques Kiladjian, Carlos Besses
Blood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe Platzbecker
Blood|October 30, 2024
Current myeloproliferative neoplasm scoring systems for clinical practiceHélène Pasquer, Jean-Jacques Kiladjian, Lina Benajiba
Blood|March 11, 2011
The renaissance of interferon therapy for the treatment of myeloid malignanciesJean-Jacques Kiladjian, Ruben A Mesa, Ronald Hoffman
Blood|March 4, 2026
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement and PemigatinibAlessandro M Vannucchi, Jay L Patel, Jean-Jacques Kiladjian
Expert Review of Hematology|February 5, 2013
Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosisRichard T Silver, Jean-Jacques Kiladjian, Hans Carl Hasselbalch
Annals of Hematology|August 7, 2024
Myeloproliferative neoplasms: young patients, current data and future considerationsMarta Sobas, Jean-Christophe Ianotto, Jean-Jacques Kiladjian, et al.
Expert Review of Hematology|May 19, 2015
Ruxolitinib for the treatment of patients with polycythemia veraJean-Jacques Kiladjian, Elliott F Winton, Moshe Talpaz, et al.
Cancer|February 19, 2024
Myelofibrosis: Current unmet needs, emerging treatments, and future perspectivesClaire N Harrison, Jean-Jacques Kiladjian, Steffen Koschmieder, et al.
Leukemia|March 31, 2023
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscapeNabih Maslah, Lina Benajiba, Stephane Giraudier, et al.
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Annals of Hematology|March 9, 2019
Thromboembolic events in polycythemia veraMartin Griesshammer, Jean-Jacques Kiladjian, Carlos Besses
Blood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe Platzbecker
Blood|October 30, 2024
Current myeloproliferative neoplasm scoring systems for clinical practiceHélène Pasquer, Jean-Jacques Kiladjian, Lina Benajiba
Blood|March 11, 2011
The renaissance of interferon therapy for the treatment of myeloid malignanciesJean-Jacques Kiladjian, Ruben A Mesa, Ronald Hoffman
Blood|March 4, 2026
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement and PemigatinibAlessandro M Vannucchi, Jay L Patel, Jean-Jacques Kiladjian
Expert Review of Hematology|February 5, 2013
Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosisRichard T Silver, Jean-Jacques Kiladjian, Hans Carl Hasselbalch
Annals of Hematology|August 7, 2024
Myeloproliferative neoplasms: young patients, current data and future considerationsMarta Sobas, Jean-Christophe Ianotto, Jean-Jacques Kiladjian, et al.
Expert Review of Hematology|May 19, 2015
Ruxolitinib for the treatment of patients with polycythemia veraJean-Jacques Kiladjian, Elliott F Winton, Moshe Talpaz, et al.
Cancer|February 19, 2024
Myelofibrosis: Current unmet needs, emerging treatments, and future perspectivesClaire N Harrison, Jean-Jacques Kiladjian, Steffen Koschmieder, et al.
Leukemia|March 31, 2023
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscapeNabih Maslah, Lina Benajiba, Stephane Giraudier, et al.
Pageof 21